Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Yodoi

Showing results (61-70 of 269) with videos related to

Pageof 27
Sort By:
Gene|January 23, 1995
Structure of the mouse thioredoxin-encoding gene and its processed pseudogeneM Matsui, Y Taniguchi, K Hirota, et al.
Journal of Immunological Methods|February 15, 1991
Detection of IgA binding site by flow cytometry with fluorescent microspheresT Shimada, H Yoshida, H Tokumoto, et al.
Princess Takamatsu Symposia|January 1, 1988
IL-2 receptor and Fc epsilon R2 gene activation in lymphocyte transformation: possible roles of ATL-derived factorJ Yodoi, Y Tagaya, H Masutani, et al.
IUBMB Life|January 25, 2002
Redox regulation by thioredoxin and thioredoxin-binding proteinsA Nishiyama, H Masutani, H Nakamura, et al.
Neuroscience Letters|December 12, 1993
Effects of 2-mercaptoethanol on survival and differentiation of fetal mouse brain neurons cultured in vitroK Ishii, M Katayama, K Hori, et al.
Microbiology and Immunology|January 1, 1993
Cholera toxin inhibits lethal hit stage of natural killer cell-mediated cytotoxicityM Watanabe, T Kiyohara, K Murata, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1991
Induction of Fc epsilon RII/CD23 on phytohemagglutinin-activated human peripheral blood T lymphocytes. I. Enhancement by IL-2 and IL-4T Kawabe, N Maekawa, Y Maeda, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1987
Interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptorsR J Robb, C M Rusk, J Yodoi, et al.
Oncology Research|January 1, 1995
Cell cycle inhibition of HTLV-I transformed T cell lines by retinoic acid: the possible therapeutic use of thioredoxin reductase inhibitorsY U-Taniguchi, K Furuke, H Masutani, et al.
FEBS Letters|November 29, 1993
Alternative transcripts of the human CD23/Fc epsilon RII. A possible novel mechanism of generating a soluble isoform in the type-II cell surface receptorM Matsui, R Nunez, Y Sachi, et al.
Pageof 27

Showing results (61-70 of 269) with videos related to

Sort By:
Pageof 27
Gene|January 23, 1995
Structure of the mouse thioredoxin-encoding gene and its processed pseudogeneM Matsui, Y Taniguchi, K Hirota, et al.
Journal of Immunological Methods|February 15, 1991
Detection of IgA binding site by flow cytometry with fluorescent microspheresT Shimada, H Yoshida, H Tokumoto, et al.
Princess Takamatsu Symposia|January 1, 1988
IL-2 receptor and Fc epsilon R2 gene activation in lymphocyte transformation: possible roles of ATL-derived factorJ Yodoi, Y Tagaya, H Masutani, et al.
IUBMB Life|January 25, 2002
Redox regulation by thioredoxin and thioredoxin-binding proteinsA Nishiyama, H Masutani, H Nakamura, et al.
Neuroscience Letters|December 12, 1993
Effects of 2-mercaptoethanol on survival and differentiation of fetal mouse brain neurons cultured in vitroK Ishii, M Katayama, K Hori, et al.
Microbiology and Immunology|January 1, 1993
Cholera toxin inhibits lethal hit stage of natural killer cell-mediated cytotoxicityM Watanabe, T Kiyohara, K Murata, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1991
Induction of Fc epsilon RII/CD23 on phytohemagglutinin-activated human peripheral blood T lymphocytes. I. Enhancement by IL-2 and IL-4T Kawabe, N Maekawa, Y Maeda, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1987
Interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptorsR J Robb, C M Rusk, J Yodoi, et al.
Oncology Research|January 1, 1995
Cell cycle inhibition of HTLV-I transformed T cell lines by retinoic acid: the possible therapeutic use of thioredoxin reductase inhibitorsY U-Taniguchi, K Furuke, H Masutani, et al.
FEBS Letters|November 29, 1993
Alternative transcripts of the human CD23/Fc epsilon RII. A possible novel mechanism of generating a soluble isoform in the type-II cell surface receptorM Matsui, R Nunez, Y Sachi, et al.
Pageof 27